Crinetics Pharmaceuticals, Inc.·5

Feb 11, 4:06 PM ET

Krasner Alan Seth 5

5 · Crinetics Pharmaceuticals, Inc. · Filed Feb 11, 2020

Insider Transaction Report

Form 5
Period: 2019-12-31
Krasner Alan Seth
Chief Medical Officer
Transactions
  • Other

    Common Stock

    2019-05-20$14.45/sh+1,471$21,2564,941 total
Footnotes (1)
  • [F1]Shares purchased under Crinetics Pharmaceuticals, Inc 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

Documents

1 file
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION